Emcure slashes obesity drug Poviztra price by up to 55% amid competition

April 2, 2026
No Comments
6 Min Read

Emcure cuts Poviztra prices by up to 55% following Novo Nordisk’s move, lowering monthly treatment costs for semaglutide-based obesity therapy in India

Source :- Companies Read More

Share it :

Leave a Reply Cancel reply

Get free tips and resources right in your inbox, along with 10,000+ others

Latest Post

India’s share in global market cap slips to 3% in March amid Middle East war concerns: Report

April 2, 2026

Noon emerges from stealth with $44 million for AI design tool

April 2, 2026

Nalco posts record FY26 performance with 77 lakh tonnes bauxite evacuation

April 2, 2026

JLR Q4 sales rise 61% as production normalised after cyber attack

April 2, 2026

Tesla shares drop over 4.5% as Q1 deliveries and production miss estimates

April 2, 2026

RBI clears Emirates NBD’s $3 billion acquisition of up to 74% in RBL Bank

April 2, 2026

Emcure slashes obesity drug Poviztra price by up to 55% amid competition

Leave a Reply Cancel reply

Get free tips and resources right in your inbox, along with 10,000+ others

Categories

Latest Post

Categories

Useful Link

Company